Medical Condition

cardiomyopathies

Total Trials

11

Recruiting Now

11

Trial Phases

Phase 3, Phase 1

ClinicalMetric tracks all active clinical trials for cardiomyopathies sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — cardiomyopathies Clinical Trials

How many clinical trials are currently recruiting for cardiomyopathies?

ClinicalMetric currently tracks 11 actively recruiting clinical trials for cardiomyopathies, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 11. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for cardiomyopathies?

cardiomyopathies research spans Phase 1 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a cardiomyopathies clinical trial?

Eligibility criteria for cardiomyopathies trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 3

Top Sponsors

National University of Ireland, Galway, Ireland 1 trial

University of Athens 1 trial

Oslo University Hospital 1 trial

Tulane University 1 trial

First Affiliated Hospital Xi'an Jiaotong University 1 trial

Recruiting Clinical Trials

NCT05921279

Recruiting

Understanding CARdiac Events in Breast Cancer

National University of Ireland...

View Trial →

NCT06949748

Recruiting

Flecainide in Idiopathic Premature Ventricular Contractions and Related Cardiomyopathy

Non-Invasive Method for Evaluation of Cardiac Resynchronization Therapy

Oslo University Hospital

View Trial →

NCT04843371

Recruiting

PPG to Predict Ejection Fraction and Other Echographic Data in the General Population

Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics

First Affiliated Hospital Xi'a...

View Trial →

NCT06978998

Recruiting

Validation of the Prognostic Impact of a Retinal Photograph-based Cardiovascular Disease Risk Stratification System in de Novo HFrEF

Pediatric Cardiomyopathy Mutation Analysis

A Preventive, Multidisciplinary Primary Care Intervention Organized Around a Therapeutic Garden: Acceptability to Patients Suffering from Cardio-neurovascular Pathology and to Those Involved in the Action.

Assistance Publique Hopitaux D...

View Trial →

NCT02824822

Recruiting

Genetic Markers of Cardiovascular Disease in Epilepsy

CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine

Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia

Weill Medical College of Corne...

View Trial →

Related Conditions

heart failure (4) myocarditis (2) breast cancer (1) cardiotoxicity (1) chemotherapeutic toxicity (1) oncology (1) premature ventricular beats (1) premature ventricular complexes (1) premature ventricular contraction pvc (1) arrhythmia ventricular (1) ventricular dysfunction left (1) ventricular dysfunction (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology